(Q33178217)

23 July 2017

An in vitro selected binding protein (affibody) shows conformation-dependent recognition of the respiratory syncytial virus (RSV) G protein (English)

1 reference

23 July 2017

7

Uhlén M

1 reference

23 July 2017

Hansson M

1

1 reference

23 July 2017

Ringdahl J

2

1 reference

23 July 2017

Robert A

3

1 reference

23 July 2017

Power U

4

1 reference

23 July 2017

Goetsch L

5

1 reference

23 July 2017

Nguyen TN

6

1 reference

23 July 2017

Ståhl S

8

1 reference

23 July 2017

Nygren PA

9

1 reference

23 July 2017

1 March 1999

1 reference

Immunotechnology : an international journal of immunological engineering

23 July 2017

1 reference

23 July 2017

4

1 reference

23 July 2017

3-4

1 reference

23 July 2017

237-252

1 reference

In vitro selection from protein and peptide libraries

23 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Identification of biologically active peptides using random libraries displayed on phage.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Phage display of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Antibody phage display technology and its applications.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Scaffolds for engineering novel binding sites in proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

A synthetic IgG-binding domain based on staphylococcal protein A.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

A combinatorial library of an alpha-helical bacterial receptor domain

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Single-step recovery of a secreted recombinant protein by expanded bed adsorption

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Hydrophobicity engineering to increase solubility and stability of a recombinant protein from respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Two distinct subtypes of human respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

The serum albumin-binding region of streptococcal protein G (BB) potentiates the immunogenicity of the G130-230 RSV-A protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

pUR 250 allows rapid chemical sequencing of both DNA strands of its inserts

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Mutational analysis of the interaction between staphylococcal protein A and human IgG1.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

High-level production of uniformly ¹⁵N- and ¹³C-enriched fusion proteins in Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Gene regulation at the right operator (OR) bacteriophage lambda. I. OR3 and autogenous negative control by repressor

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Multiple affinity domains for the detection, purification and immobilization of recombinant proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Analysis and use of the serum albumin binding domains of streptococcal protein G

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

A dual expression system for the generation, analysis and purification of antibodies to a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Production of a thermostable DNA polymerase by site-specific cleavage of a heat-eluted affinity fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Hydrophobicity engineering to facilitate surface display of heterologous gene products on Staphylococcus xylosus

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Calculation of protein extinction coefficients from amino acid sequence data

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Competitive elution of protein A fusion proteins allows specific recovery under mild conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

A subgroup-specific antigenic site in the G protein of respiratory syncytial virus forms a disulfide-bonded loop

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

Intracellular antibodies (intrabodies) as research reagents and therapeutic molecules for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2898%2900026-8

7 January 2021

10.1016/S1380-2933(98)00026-8

Identifiers

DOI

1 reference

23 July 2017

1 reference